Covalent dimerization of vascular permeability factor/vascular endothelial growth factor is essential for its biological activity. Evidence from Cys to Ser mutations

Andy J.G. Pötgens(Radboud University Nijmegen), R M de Waal, D. J. Ruiter(Radboud University Nijmegen), Robin Jeanna Vermeulen(Radboud University Nijmegen), J.G.G. Schoenmakers(Radboud University Nijmegen), A. Bakker(Radboud University Nijmegen), Nicolette H. Lubsen(Radboud University Nijmegen), M C van Altena(Radboud University Nijmegen)
Journal of Biological Chemistry
December 1, 1994
10.1016/s0021-9258(20)30073-9
Cited by 103

Related Papers

N-ras mutations in human cutaneous melanoma from sun-exposed body sites.
|Molecular and Cellular Biology|1989|280
Aneurysmal bone cysts.A clinicopathological study of 105 cases
|Cancer|1977|269
c‐myc down‐regulates class I HLA expression in human melanomas.
|The EMBO Journal|1988|257
Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the World Health Organization Melanoma Program Trial 15, and the North American Perfusion Group Southwest Oncology Group-8593.
|Journal of Clinical Oncology|1998|246
Final results of the EORTC 18871/DKG 80-1 randomised phase III trial
|European Journal of Cancer|2003|240